Investigation and a pending class action lawsuit on behalf of wholesalers and pharmacies, alleging that AztraZeneca used a fraudulently obtained patent to block the entry of lower priced generic competitors to their brand-name prescription medication, sold under the brand name Toprol XL.
The class action lawsuit alleges that AztraZeneca engaged in the anticompetitive conduct forced all purchasers to overpay for this prescription medication.
Do not change medications without first consulting your doctor.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.